Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells

Hematology Journal

Volumn 5, Issue 4, 2004, Pages 329-340

  Eyrich, Matthias ^a   Leiler, Christine ^a   Croner, Tanja ^a   Lang, Peter ^a   Schumm, Michael ^a   Mascher, Beate ^a   Schilbach, Karin ^a   Klingebiel, Thomas ^b   Handgretinger, Rupert ^c   Niethammer, Dietrich ^a   Schlegel, Paul G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CD34+ selection; Cytokine production; Hematopoietic stem cell transplantation; Immune reconstitution; T cell deficiency

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; OKT 3; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENOLEUKODYSTROPHY; ALBERS SCHOENBERG DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; CELL SELECTION; CELL STIMULATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DONOR; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HOST; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCYTHEMIA VERA; PROTEIN SECRETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; WHOLE BODY RADIATION; WISKOTT ALDRICH SYNDROME;

ANTIGENS, CD; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOKINES; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 4544328874     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200397     Document Type: Article

References (46)

1. Beelen DW, Ottinger HD, Elmaagacli A, Scheulen B, Basu O, Kremens B et al. Transplantation of filgrastim- mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997; 90: 4725-4735.
2. Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 2001; 19: 108-117.
3. Eyrich M, Lang P, Lal S, Bader P, Klingebiel T, Handgretinger R et al. A prospective analysis of the pattern of immune reconstitution following transplantation of HLA-disparate hematopoietic stem cells from parental donors. Br J Haematol 2001; 114: 422-432.
4. Heitger A, Winklehner P, Obexer P, Eder J, Zelle-Rieser C, Kropshofer G et al. Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations. Blood 2002; 99: 4053-4062.
5. Hebib NC, Deas O, Rouleau M, Durrbach A, Charpentier B, Beaujean F et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. Blood 1999; 94: 1803-1813.
6. Holler E, Kolb HJ, Moller A, Kempeni J, Liesenfeld S, Pechumer H et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011-1016.
7. Krenger W, Ferrara JL. Dysregulation of cytokines during graft-versus-host disease. J Hematother 1996; 5: 3-14.
8. Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Leblanc P, Symann ML. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800-3807.
9. Schlenke P, Sheikhzadeh S, Weber K, Wagner T, Kirchner H. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 251-257.
10. Singh RK, Varney ML, Ino K, Vose JM, Bierman PJ, Talmadge JE. Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non- Hodgkin's lymphoma patients. Exp Hematol 2000; 28: 499-507.
11. Mitra DK, Singh HP, Singh M, Alwadi A, Kochupillai V, Raina V et al. Reconstitution of naive T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer. Transplantation 2002; 73: 1336-1339.
12. Leblond V, Othman TB, Blanc C, Theodorou I, Choquet S, Sutton L et al. Expansion of CD4+ CD7- T cells, a memory subset with preferential interleukin-4 production, after bone marrow transplantation. Transplantation 1997; 64:1453-1459.
13. Mendes AV, Benard G, Pereira CB, Kallas EG, Duarte AJ, Pannuti CS et al. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation. Acta Haematol 2002; 107: 187-194.
14. Tanaka J, Imamura M, Kasai M, Zhu X, Kobayashi S, Imai K et al. Cytokine gene expression by concanavalin A- stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease. Bone Marrow Transplant 1994; 14: 695-701.
15. Korholz D, Kunst D, Hempel L, Sohngen D, Heyll A, Bonig H et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 691-695.
16. Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J et al. Pharmacologic doses of granulocyte colony- stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000; 95: 2269-2274.
17. Volpi I, Perruccio K, Tosti A, Capanni M, Ruggeri L, Posati S et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype- mismatched hematopoietic transplants. Blood 2001; 97: 2514 2521.
18. Handgretinger R, Schumm M, Lang P, Greil J, Reiter A, Bader P et al. Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 1999; 872: 351-362.
19. Lang P, Handgretinger R, Niethammer D, Schlegel PG, Schumm M, Greil J et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 2003; 101: 1630-1636.
20. Schumm M, Lang P, Taylor G, Kuci S, Klingebiel T, Buhring HJ et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209-218.
21. Schlegel P, Eyrich M, Bader P, Handgretinger R, Lang P, Niethammer D et al. OKT-3 based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. Br J Haematol 2000; 111: 668-673.
22. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus- host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
23. Mascher B, Schlenke P, Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J Immunol Methods 1999; 223: 115-121.
24. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159: 197-207.
25. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992; 13: 215-218.
26. Davison GM, Novitzky N, Kline A, Thomas V, Abrahams L, Hale G et al. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells. Transplantation 2000; 69: 1341-1347.
27. Eyrich M, Leiler C, Lang P, Schilbach K, Schumm M, Bader P et al. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34 + peripheral blood stem cells from unrelated donors versus recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003; 32: 379-390.
28. Hanenberg H, Dilloo D, Laws HJ, Zessack N, Heyll A, Burdach S. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies. Exp Hematol 1995; 23: 1543-1552.
29. Sheet NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5: 171-177.
30. Swain SL, Croft M, Dubey C, Haynes L, Rogers P, Zhang X et al. From naive to memory T cells. Immunol Rev 1996; 150:143-167.
31. Akbar AN, Salmon M, Janossy G. The synergy between naive and memory T cells during activation. Immunol Today 1991; 12: 184-188.
32. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof Garde SR, Klein MR et al. Phenotypic and functional separation of memory and effector human CD8 + T cells. J Exp Med 1997; 186: 1407-1418.
33. Chipeta J, Komada Y, Zhang XL, Deguchi T, Sugiyama K, Azuma E et al. CD4 + and CD8 + cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. Cell Immunol 1998; 183: 149-156.
34. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92: 11-18.
35. Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A et al. Tolerance induction by 'megadose' hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65: 1386-1393.
36. Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P et al. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Bone Marrow Transplant 2003; 32: 217-223.
37. Ziegler SF, Levin SD, Johnson L, Copeland NG, Gilbert DJ, Jenkins NA et al. The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. J Immunol 1994; 152: 1228-1236.
38. Nakamura S, Sung SS, Bjorndahl JM, Fu SM. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J Exp Med 1989; 169: 677-689.
39. D'Ambrosio D, Cantrell DA, Frati L, Santoni A, Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol 1994; 24: 616-620.
40. D'Ambrosio D, Trotta R, Vacca A, Frati L, Santoni A, Gulino A et al. Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals. Eur J Immunol 1993; 23: 2993-2997.
41. Santis AG, Campanero MR, Alonso JL, Tugores A, Alonso MA, Yague E et al. Tumor necrosis factor-alpha production induced in T lymphocytes through We AIM/ CD69 activation pathway. Eur J Immunol 1992; 22: 1253-1259.
42. Moses CT, Thorstenson KM, Jameson SC, Khoruts A. Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci USA 2003; 100: 1185-1190.
43. Moller J, Hofmann B, Jacobsen N, Ryder LP, Platz P, Dickmeiss E et al. Defective T-cell stimulatory pathways in patients after allogeneic bone marrow transplantation (BMT) in man. Apmis 1993; 101: 480-486.
44. Pignata C, Sanghera JS, Soiffer RJ, Chartier S, Eder M, Pelech SL et al. Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation. Blood 1996; 88: 2334-2341.
45. Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cells inhibit T cell function. J Leukoc Biol 1997; 61: 583-591.
46. Tan R, Xu X, Ogg GS, Hansasuta P, Dong T, Rostron T et al. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood 1999; 93: 1506-1510.